Phitys I™ Percutaneous Left Ventricular Assist System Study - Trial NCT06357026
Access comprehensive clinical trial information for NCT06357026 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai NewMed Medical Co., Ltd. and is currently Not yet recruiting. The study focuses on Coronary Artery Disease. Target enrollment is 344 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai NewMed Medical Co., Ltd.
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2026
Primary Outcome
Incidence of freedom from major adverse cardiovascular and cerebrovascular events (MACCE)
Summary
The primary purpose of this clinical trial is to evaluate the safety and efficacy of the
 percutaneous left ventricular assist system versus intra-aortic balloon pump (IABP) for
 Circulatory Support during High-risk PCI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06357026
Device Trial